Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Canine cerebral leishmaniasis: Potential role of matrix metalloproteinase-2 in the development of neurological disease

Texto completo
Autor(es):
Melo, Guilherme D. ; Marcondes, Mary [1] ; Machado, Gisele F. [1]
Número total de Autores: 3
Afiliação do(s) autor(es):
[1] Univ Estadual Paulista, UNESP, Coll Vet Med, Dept Anim Clin Surg & Reprod, Sao Paulo - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY; v. 148, n. 3-4, p. 260-266, AUG 15 2012.
Citações Web of Science: 11
Resumo

Matrix metalloproteinases (MMPs) are a group of calcium- and zinc-dependent endopeptidases that are involved in maintaining the extracellular matrix. MMP-2 and MMP-9 are thought to be related to the disruption of the blood-brain-barrier (BBB) by their ability to cleave type IV collagen, the main component of the basal membrane. To establish the presence of MMP-2 and MMP-9 in the pathogenesis of canine cerebral leishmaniasis, we examined the levels of these metalloproteinases in the cerebrospinal fluid (CSF) and serum of dogs with visceral leishmaniasis and neurological symptoms (n = 16) and in the CSF and serum of uninfected healthy dogs (n =10) using zymography. In the CSF of dogs with cerebral leishmaniasis there was a massive presence of active MMP-2, whereas only the levels of both proMMP-2 and proMMP-9 were elevated in the serum. Although the detected MMP activity in the CSF might merely be related to CNS inflammation, these enzymes may also play a collaborative role in the disease progression. Both MMP-2 and MMP-9 are known to target critical constituents of the BBB, and once activated, they may promote cerebral barrier breakdown, allowing the entrance of inflammatory cells and proteins within the nervous system milieu. (c) 2012 Elsevier B.V. All rights reserved. (AU)

Processo FAPESP: 10/12473-2 - Avaliação da expressão gênica de citocinas no encéfalo de cães com leishmaniose visceral
Beneficiário:Guilherme Dias de Melo
Modalidade de apoio: Bolsas no Brasil - Mestrado